Ferrer Internacional S.A.

🇨🇱Chile
Ownership
-
Employees
-
Market Cap
-
Website

Safety Study of Ciclopirox Olamine Cream for Dermatomycoses in Children

Phase 4
Terminated
Conditions
Interventions
First Posted Date
2012-07-20
Last Posted Date
2012-07-20
Lead Sponsor
Ferrer Internacional S.A.
Target Recruit Count
21
Registration Number
NCT01646580

Single Dose Study to Compare the Pharmacodynamics of Torasemide-PR 10 mg,Torasemide-IR 10 mg and Furosemide-IR 40 mg in Patients With Compensated Heart Failure

First Posted Date
2012-03-09
Last Posted Date
2013-04-25
Lead Sponsor
Ferrer Internacional S.A.
Target Recruit Count
8
Registration Number
NCT01549158
Locations
🇪🇸

Centre d'Investigació de Medicaments (CIM), Hospital de la Santa Creu i Sant Pau, Barcelona, Spain

Efficacy and Safety of Ozenoxacin 1% Cream Versus Placebo in the Treatment of Patients With Impetigo

First Posted Date
2011-07-19
Last Posted Date
2016-07-01
Lead Sponsor
Ferrer Internacional S.A.
Target Recruit Count
465
Registration Number
NCT01397461
Locations
🇩🇪

Georg Popp, Augsburg, Germany

🇩🇪

Diamant Thaci, Frankfurt/Main, Germany

🇿🇦

Yacoob Vahed, Welkom, South Africa

and more 16 locations

Pharmacodynamic Clinical Trial of Cardiovascular Polypill on LDL Cholesterol

First Posted Date
2011-05-30
Last Posted Date
2013-04-24
Lead Sponsor
Ferrer Internacional S.A.
Target Recruit Count
107
Registration Number
NCT01362218
Locations
🇪🇸

Hospital Clinic, Barcelona, Spain

Arasertaconazole Nitrate Pessaries - Dose Finding Study for the Vulvovaginal Candidiasis (VVC) Treatment

First Posted Date
2010-06-15
Last Posted Date
2013-10-09
Lead Sponsor
Ferrer Internacional S.A.
Target Recruit Count
229
Registration Number
NCT01144286
Locations
🇪🇸

Ferrer Internacional S.A., Barcelona, Spain

Study to Assess the Efficacy and Safety of GF-001001-00 Cream in Secondarily-Infected Traumatic Lesions

First Posted Date
2009-11-01
Last Posted Date
2010-06-09
Lead Sponsor
Ferrer Internacional S.A.
Target Recruit Count
200
Registration Number
NCT01005771
Locations
🇩🇪

Dermatologische Praxis, Mahlow, Germany

A Pharmacodynamic Study to Evaluate the Effect of a Fixed Dose Combination Pill on Blood Pressure

Phase 2
Terminated
Conditions
Interventions
First Posted Date
2009-10-30
Last Posted Date
2012-07-26
Lead Sponsor
Ferrer Internacional S.A.
Target Recruit Count
38
Registration Number
NCT01005290
Locations
🇺🇸

Mount Sinai Medical Center, New York, New York, United States

A Pharmacodynamic Study to Evaluate the Effect of a Fixed Dose Combination Pill on Low Density Lipoprotein (LDL) Cholesterol

First Posted Date
2009-10-30
Last Posted Date
2012-08-31
Lead Sponsor
Ferrer Internacional S.A.
Target Recruit Count
36
Registration Number
NCT01004705
Locations
🇺🇸

Mount Sinai Medical Center, New York, New York, United States

Effect of a New Formulation of Torasemide (Prolonged Release)on Myocardial Fibrosis in Patients With Heart Failure.

First Posted Date
2006-12-12
Last Posted Date
2009-07-15
Lead Sponsor
Ferrer Internacional S.A.
Target Recruit Count
142
Registration Number
NCT00409942
Locations
🇪🇸

Central Hospital, Oviedo, Asturias, Spain

🇪🇸

Centelles - Primar Care Centre, Centellas, Barcelona, Spain

🇪🇸

San Jorge Hospital, Huesca, Spain

and more 20 locations

Hypertension Study: Multinational Torasemide Trial in Mild to Moderate Hypertension.

Phase 4
Completed
Conditions
First Posted Date
2006-06-07
Last Posted Date
2015-03-06
Lead Sponsor
Ferrer Internacional S.A.
Target Recruit Count
388
Registration Number
NCT00334386
© Copyright 2024. All Rights Reserved by MedPath